15.20 - 15.35 A PHASE 2 STUDY OF LERONLIMAB FOR MI
Post# of 148179
(Total Views: 516)
Posted On: 10/07/2020 10:45:11 AM
15.20 - 15.35 A PHASE 2 STUDY OF LERONLIMAB FOR MILD TO MODERATE CORONAVIRUS DISEASE 2019 (COVID-19) HARISH SEETHAMRAJU Montefiore Medical Center, Bronx, NY, USA
That's 3:20 p.m. GMT, which is 4:20 p.m. London, 11:20 a.m. Eastern, and 8:20 a.m. Pacific. (That's in less than an hour!)
That's 3:20 p.m. GMT, which is 4:20 p.m. London, 11:20 a.m. Eastern, and 8:20 a.m. Pacific. (That's in less than an hour!)
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼